Burn

product on market Capsule FighterDiet by Pauline Nordin Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 56% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains caffeine and green tea extract, which have moderate evidence for supporting metabolic rate and alertness. L-carnitine and glucuronolactone are included for energy metabolism, though clinical evidence for significant weight loss is limited. Niacin supports cellular energy production as a key cofactor.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Burn
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
56%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

20 mg (100% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
200 mg
Market median: 180.0mg (239 products) 49 studies (A:1, B:19)
Glucuronolactone
150 mg
Phenylethylamine HCl
100 mg
Yohimbe bark extract
37.5 mg
Market median: 983.0mg (16 products) 7 studies (A:0, B:1)
Vinpocetine
10 mg

Other Ingredients

Magnesium Stearate Hypromellose
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Formulation Notes

Boost fat loss Boost metabolism Increase performance

Metadata

Product Details

DSLD Entry Date2020-01-25
Product TypeOther Combinations
FormCapsule
DSLD ID211413
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.